Show simple item record

dc.contributor.authorDoshi, Peter
dc.contributor.authorJefferson, Tom
dc.date.accessioned2017-05-25T01:16:42Z
dc.date.available2017-05-25T01:16:42Z
dc.date.issued2014-04-10
dc.identifier.citationJefferson, T. & Doshi, P. (2014). Multisystem failure: the story of anti-influenza drugs. BMJ 2014;348:g2263. DOI: https://doi.org/10.1136/bmj.g2263en_US
dc.identifier.urihttp://hdl.handle.net/10713/6609
dc.descriptionIn 2013 the Cochrane team, with the help of the BMJ’s open data campaign, was able to access full clinical study reports on neuraminidase inhibitors. Tom Jefferson and Peter Doshi explain what the new systematic review found and how a series of failures meant that decisions about these drugs were made without the full evidenceen_US
dc.description.urihttp://bmj.com/cgi/content/full/bmj.g2263?ijkey=EhOcENYErEK2IJT&keytype=ref
dc.language.isoen_USen_US
dc.publisherBMJ Publishing Groupen_US
dc.subjectneuraminidase inhibitorsen_US
dc.subjectclinical study reportsen_US
dc.subjectdrug regulationsen_US
dc.subjectincomplete dataen_US
dc.subject.meshInfluenza, Human--drug therapyen_US
dc.subject.meshAntiviral Agentsen_US
dc.subject.meshOseltamiviren_US
dc.subject.meshZanamiviren_US
dc.titleMultisystem failure: the story of anti-influenza drugsen_US
dc.typeArticleen_US
dc.identifier.doi10.1136/bmj.g2263
dc.identifier.pmid24721793
dc.identifier.ispublishedNoen_US
dc.description.urinameClick here for the free full-text article on publisher’s websiteen_US
refterms.dateFOA2019-02-19T18:16:09Z


Files in this item

Thumbnail
Name:
Doshi_BMJ_Multisystem_Failure.pdf
Size:
245.9Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record